Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Bioorganic chemistry
2026
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/41554206/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266097699979264 |
|---|---|
| author | Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang |
| author_facet | Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang |
| collection | PubMed - marine biology |
| contents | Mucoadhesive lignin-liposome nanocarriers of coptisine: A multifunctional strategy against antibiotic-resistant Helicobacter pylori biofilms. Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang Helicobacter pylori Biofilms Anti-Bacterial Agents Liposomes Berberine Animals Microbial Sensitivity Tests Lignin Mice Drug Resistance, Bacterial Nanoparticles Particle Size Dose-Response Relationship, Drug Molecular Structure Drug Carriers Structure-Activity Relationship Helicobacter pylori remain a major global health challenge due to rising antibiotic resistance, persistent biofilm formation, and oxidative stress-mediated gastric pathogenesis. Innovative therapeutic approaches are urgently required to overcome the limitations of conventional antibiotic regimens. We engineered a novel mucoadhesive nanocarrier (COP-LIG@LIPSNCs) by synergistically integrating biofilm-disrupting lignin nanoparticles with biocompatible liposomal vesicles to encapsulate the bioactive isoquinoline alkaloid coptisine. The formulations were comprehensively characterized using DLS, FTIR, XRD, and TEM. Antibacterial and antibiofilm were evaluated through MIC/MBC assays, time-kill kinetics, confocal bioimaging, and electron microscopy. Cytocompatibility was assessed using L929 fibroblasts, while in vivo mucoadhesion and therapeutic efficacy were investigated in a murine model. COP-LIG@LIPSNCs exhibited a stable nanoscale size (∼197 nm; PDI 0.152; ζ-potential -31.4 mV, EE% 89.2 ± 1.4 % and LE% 2.1 ± 0.08 %). COP-LIG@LIPSNCs displayed sustained behaviour, releasing 42.28 ± 4.2 % in SGF and 58.17 ± 4.1 % in SIF after 48 h, with strong mucoadhesion. Antibacterial studies demonstrated potent activity against H. pylori (MIC 32 μg/mL; MBC 64 μg/mL), achieving >92 % eradication of planktonic cells and ∼ 89 % disruption of established biofilms within 24 h. CLSM and SEM confirmed nanocarrier penetration, membrane disruption, and biofilm dispersion. Surprisingly, the H. pylori burden of the COP@LIG@LIP group was significantly lower at 1.38 × 10 CFU/g compared to negative control, indicating the effective treatment effect of killing H. pylori in vivo. COP-LIG@LIPSNCs represent a novel and multifunctional nanoplatform that synergistically combines antimicrobial, antibiofilm, and antioxidant actions. This study pioneers a sustainable strategy using lignin to create an advanced therapeutic alternative, showing significant promise for managing drug-resistant H. pylori infections. |
| format | Artículo científico |
| id | pubmed_41554206 |
| institution | PubMed |
| language | en |
| publishDate | 2026 |
| publisher | Bioorganic chemistry |
| record_format | pubmed |
| spellingShingle | Mucoadhesive lignin-liposome nanocarriers of coptisine: A multifunctional strategy against antibiotic-resistant Helicobacter pylori biofilms. Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang Helicobacter pylori Biofilms Anti-Bacterial Agents Liposomes Berberine Animals Microbial Sensitivity Tests Lignin Mice Drug Resistance, Bacterial Nanoparticles Particle Size Dose-Response Relationship, Drug Molecular Structure Drug Carriers Structure-Activity Relationship Mucoadhesive lignin-liposome nanocarriers of coptisine: A multifunctional strategy against antibiotic-resistant Helicobacter pylori biofilms. Sharaf, Mohamed Al-Laith, Zainab Naser Khan, Tehsin Ullah Elkelish, Amr Abdel-Maksoud, Mohamed S Elrefaei, Nadia G Alawam, Abdullah S Liu, Chen-Guang Helicobacter pylori Biofilms Anti-Bacterial Agents Liposomes Berberine Animals Microbial Sensitivity Tests Lignin Mice Drug Resistance, Bacterial Nanoparticles Particle Size Dose-Response Relationship, Drug Molecular Structure Drug Carriers Structure-Activity Relationship Helicobacter pylori remain a major global health challenge due to rising antibiotic resistance, persistent biofilm formation, and oxidative stress-mediated gastric pathogenesis. Innovative therapeutic approaches are urgently required to overcome the limitations of conventional antibiotic regimens. We engineered a novel mucoadhesive nanocarrier (COP-LIG@LIPSNCs) by synergistically integrating biofilm-disrupting lignin nanoparticles with biocompatible liposomal vesicles to encapsulate the bioactive isoquinoline alkaloid coptisine. The formulations were comprehensively characterized using DLS, FTIR, XRD, and TEM. Antibacterial and antibiofilm were evaluated through MIC/MBC assays, time-kill kinetics, confocal bioimaging, and electron microscopy. Cytocompatibility was assessed using L929 fibroblasts, while in vivo mucoadhesion and therapeutic efficacy were investigated in a murine model. COP-LIG@LIPSNCs exhibited a stable nanoscale size (∼197 nm; PDI 0.152; ζ-potential -31.4 mV, EE% 89.2 ± 1.4 % and LE% 2.1 ± 0.08 %). COP-LIG@LIPSNCs displayed sustained behaviour, releasing 42.28 ± 4.2 % in SGF and 58.17 ± 4.1 % in SIF after 48 h, with strong mucoadhesion. Antibacterial studies demonstrated potent activity against H. pylori (MIC 32 μg/mL; MBC 64 μg/mL), achieving >92 % eradication of planktonic cells and ∼ 89 % disruption of established biofilms within 24 h. CLSM and SEM confirmed nanocarrier penetration, membrane disruption, and biofilm dispersion. Surprisingly, the H. pylori burden of the COP@LIG@LIP group was significantly lower at 1.38 × 10 CFU/g compared to negative control, indicating the effective treatment effect of killing H. pylori in vivo. COP-LIG@LIPSNCs represent a novel and multifunctional nanoplatform that synergistically combines antimicrobial, antibiofilm, and antioxidant actions. This study pioneers a sustainable strategy using lignin to create an advanced therapeutic alternative, showing significant promise for managing drug-resistant H. pylori infections. |
| title | Mucoadhesive lignin-liposome nanocarriers of coptisine: A multifunctional strategy against antibiotic-resistant Helicobacter pylori biofilms. |
| topic | Helicobacter pylori Biofilms Anti-Bacterial Agents Liposomes Berberine Animals Microbial Sensitivity Tests Lignin Mice Drug Resistance, Bacterial Nanoparticles Particle Size Dose-Response Relationship, Drug Molecular Structure Drug Carriers Structure-Activity Relationship |
| url | https://pubmed.ncbi.nlm.nih.gov/41554206/ |